Related Experiment Video
Updated: Aug 11, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Circular RNA circ-SMAD7 promoted glioma cell proliferation and metastasis by upregulating PCNA
1Department of Neurosurgery, The Ninth People's Hospital of Suzhou, Suzhou, China. zuochangyang@163.com.
Objective:
Recent studies have discovered a class of circular RNAs (circRNAs), which are dysregulated in various tumors and participate in the regulation of tumor progression. In our research, we aim to research the function of circ-SMAD7 in the progression of glioma.
Patients And Methods:
Circ-SMAD7 expression was detected by quantitative Real Time Polymerase Chain Reaction (qRT-PCR) in glioma tissue patients. Pearson's Chi-square test was used to determine the association of circ-SMAD7 expression with several clinicopathological factors. Besides, cell proliferation assay, cell cycle assay, transwell assay, and Matrigel assay were conducted to detect the function of circ-SMAD7 in glioma. In addition, the interaction between circ-SMAD7 and proliferating cell nuclear antigen (PCNA) in glioma was studied by performing qRT-PCR and Western blot assay.
Results:
Circ-SMAD7 expression was observed in glioma tissues when compared with adjacent samples. The expression of circ-SMAD7 was associated with patients' WHO stage and KPS score. Cell proliferation was inhibited and cell cycle was regulated after circ-SMAD7 was downregulated in glioma cells. Besides, cell migration and invasion were inhibited after circ-SMAD7 was downregulated in glioma cells. In addition, the mRNA and protein expression of PCNA was repressed after circ-SMAD7 was knocked down in glioma cells. Furthermore, PCNA expression level positively correlated to circ-SMAD7 expression level in glioma samples.
Conclusions:
Our study suggests that circ-SMAD7 promotes proliferation and metastasis of glioma via upregulating PCNA. Circ-SMAD7/ PCNA might be a novel therapeutic strategy in glioma.
Insights
Circular RNA SMAD7 (circ-SMAD7) promotes glioma progression by upregulating proliferating cell nuclear antigen (PCNA). Targeting the circ-SMAD7/PCNA pathway may offer a new therapeutic strategy for glioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are a class of regulatory RNAs implicated in tumor progression.
- Dysregulation of circRNAs is observed in various cancers, including glioma.
- The specific role of circ-SMAD7 in glioma pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the function of circ-SMAD7 in glioma progression.
- To explore the underlying molecular mechanism of circ-SMAD7 in glioma.
- To evaluate circ-SMAD7 as a potential therapeutic target for glioma.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to detect circ-SMAD7 expression in glioma tissues.
- Cellular assays including proliferation, cell cycle, migration, and invasion assays to assess circ-SMAD7 function.
- Western blot and qRT-PCR to analyze the interaction between circ-SMAD7 and proliferating cell nuclear antigen (PCNA).
Main Results:
- Circ-SMAD7 expression was significantly higher in glioma tissues compared to adjacent samples.
- Downregulation of circ-SMAD7 inhibited glioma cell proliferation, migration, and invasion, and regulated the cell cycle.
- Circ-SMAD7 positively correlated with PCNA expression, and its knockdown reduced PCNA mRNA and protein levels.
Conclusions:
- Circ-SMAD7 promotes glioma proliferation and metastasis by upregulating PCNA.
- The circ-SMAD7/PCNA axis represents a potential novel therapeutic strategy for glioma treatment.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

